Inventor
MUTHIAH MANOHARAN
Inventor
US
Overview
Patents· 50 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
C12NMicroorganisms or enzymes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07CAcyclic or carbocyclic compounds9%
C07DHeterocyclic compounds9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07HSugars5%
Y02ATechnologies for adaptation to climate change3%
C07KPeptides2%
C12YEnzymes2%
PatentTitleYear
12,590,305Complement component C5 iRNA compositions and methods of use thereof202612,497,613Modified oligonucleotides202512,460,206PCSK9 iRNA compositions and methods of use thereof202512,453,776Lipids and compositions for the delivery of therapeutics202512,397,013Extrahepatic delivery202512,385,044Modified double-stranded RNA agents202512,385,043Modified double-stranded RNA agents202512,378,553Modified double-stranded RNA agents202512,364,762Biodegradable lipids for the delivery of active agents202512,350,338Biodegradable lipids for the delivery of active agents202512,343,398Biodegradable lipids for the delivery of active agents202512,290,573Modified RNAi agents202512,275,938Modified RNA agents with reduced off-target effect202512,247,203Modified RNA agents with reduced off-target effect202512,241,064REVERSIR(tm) compounds202512,239,709Biodegradable lipids for the delivery of active agents202512,221,607Multi-targeted single entity conjugates202512,173,287Compositions and methods for improving strand biased202412,173,288Oligonucleotide-ligand conjugates and process for their preparation202412,168,767Modified double-stranded RNA agents202412,071,619SERPINA1 iRNA compositions and methods of use thereof202412,059,468Carbohydrate conjugates as delivery agents for oligonucleotides202412,042,541Lipids and compositions for the delivery of therapeutics202412,023,383Lipid compositions202412,005,074Extrahepatic delivery202411,944,687Carbohydrate conjugate RNA agents and process for their preparation202411,873,491Complement component C5 iRNA compositions and methods of use thereof202411,725,207Serpina1 iRNA compositions and methods of use thereof202311,679,158Biodegradable lipids for the delivery of active agents202311,666,653Carbohydrate conjugates as delivery agents for oligonucleotides202311,633,480Biodegradable lipids for the delivery of active agents202311,633,479Biodegradable lipids for the delivery of active agents202311,612,657Biodegradable lipids for the delivery of active agents202311,597,932Chirally-enriched double-stranded RNA agents202311,590,229Biodegradable lipids for the delivery of active agents202311,549,109Modified double-stranded RNA agents202311,530,408Therapeutic compositions202211,504,391Modified RNA agents with reduced off-target effect202211,427,822Modified double-stranded RNA agents202211,420,931Lipid containing formulations202211,408,001Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof202211,406,716Modified RNAi agents202211,400,158Biodegradable lipids for the delivery of active agents202211,401,517Modified double-stranded RNA agents202211,382,979Biodegradable lipids for the delivery of active agents202211,312,957Modified iRNA agents202211,246,933Biodegradable lipids for the delivery of active agents202211,207,342High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof202111,162,098Complement component C5 iRNA compositions and methods of use thereof202111,142,766Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to ALNYLAM PHARMACEUTICALS INC (46)· patent assignee history
2021Patents assigned to ETH ZUERICH (1)· patent assignee history
2021–2026Based in US· patent location history
2022–2025Patents assigned to ARBUTUS BIOPHARMA CORP (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 46 | 2021–2026 |
| ARBUTUS BIOPHARMA CORP | 4 | 2022–2025 |
| ETH ZUERICH | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 50 | 2021–2026 |